Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FSHD region gene 1 family member K, pseudogene (FRG1KP) is a member of the FSHD region gene 1 family and is classified as a pseudogene, meaning it is a segment of DNA that resembles a gene but does not encode a functional protein[4][5]. There is no experimental evidence that FRG1KP has a role in disease, drug interaction, or any characterized biological pathway. The functional FSHD region gene 1 (FRG1) is implicated in muscle and vascular development and studied in the context of facioscapulohumeral muscular dystrophy, but FRG1KP itself is nonfunctional, and thus not considered a drug target, biomarker, or mechanistic entity[1][2][3][4][5]. No conflicting information was identified about the gene’s classification as a pseudogene or its lack of therapeutic or biological function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FSHD region gene 1 family member K, pseudogene (FRG1KP).